Diabetes care product company ARKRAY USA Inc reported on Monday the launch of newest blood glucose monitoring system (BGMS) in the US, the GLUCOCARD Shine XL.
According to the company, the GLUCOCARD Shine XL blood glucose monitoring system is now available for order in the US.
Highly accurate with a large LED screen intended to facilitate quick and easy viewing of blood glucose test results, the GLUCOCARD Shine XL BGMS offers an ergonomically designed meter that provides a secure grip during testing as well as uses the same test strips as the prior GLUCOCARD Shine, which has been proven to provide highly accurate test results in an easy to use form.
ARKRAY USA Inc, which is a division of ARKRAY headquartered in Kyoto, Japan, currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the US.
Novo Nordisk to streamline operations and reinvest in diabetes and obesity growth
NICE endorses AOTI's TWO2 therapy for diabetic foot ulcers
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
OptiBiotix signs distribution deal with major weight management company
GoodRx partners with Novo Nordisk to offer Ozempic and Wegovy at USD499 per month
Ocular Therapeutix secures FDA special protocol assessment for AXPAXLI NPDR trial
MetaVia collaborates with Syntekabio to explore AI-driven indications for DA-1241
Ascletis completes participant dosing in US obesity clinical study
BioLab Holdings' amnion grafts enter multicentre clinical trial